Skip to Content
Last Updated: 04/25/2012

Community Clinical Oncology Program

The Community Clinical Oncology Program (CCOP), administered by the NCI Division of Cancer Prevention, is a comprehensive clinical trial mechanism for disseminating the latest cancer prevention and treatment research findings to the community level. A third of patients accrued to all NCI treatment trials and prevention trials are enrolled at CCOP sites.

Created in 1983, the program works in tandem with CTEP to enable patients and physicians to participate in clinical trials at 61 major research centers in 34 states, the District of Columbia, and Puerto Rico.

In 2010, 47 CCOPs and 16 minority-based CCOPs across the country received funding for participation in NCI-approved trials. Altogether, the program comprises 3,375 participating physicians, about 400 participating hospitals working on more than 300 active treatment trials, and more than 70 active prevention and control trials.

In 2010, the CTSU menu of trials was expanded to include cancer control trials supported by DCP's CCOP Research Bases which includes eight Cooperative Groups and four Cancer Centers.

About the
Associate Director

Jeffrey S. Abrams, M.D. Jeffrey S. Abrams, M.D., has led the Cancer Therapy Evaluation Program (CTEP) since June 2007.  Dr. Abrams came to CTEP in 1993 when he joined as a clinical research scientist to oversee the breast cancer treatment trials portfolio and participate in clinical trials at the NIH Clinical Center and the National Naval Medical Center. More…

For More Details
About CTEP